A Crossover Safety Study of Ferumoxytol Versus Placebo

ClinicalTrials.gov ID: NCT00255450

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00255450. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double Blind, Placebo Controlled, Crossover Design, Multicenter Study of Intravenous Ferumoxytol Compared With Placebo

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This crossover safety study will evaluate the safety of a single dose of ferumoxytol compared to placebo in patients with chronic kidney disease.

Study identification

NCT ID: NCT00255450
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: AMAG Pharmaceuticals, Inc.; Industry
Enrollment: 750 participants

Conditions and interventions

Conditions

Anemia

Interventions

ferumoxytol or placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 2005 (Type not available)
Primary completion: Not listed
Completion: Aug 2006 (Actual)
Last update posted: Nov 11, 2008

2005 – 2006

United States locations

U.S. sites: 41
U.S. states: 26
U.S. cities: 39

Facility	City	State	ZIP	Site status
Not listed	Mobile	Alabama	36608	—
Not listed	Phoenix	Arizona	85012	—
Not listed	Mountain View	California	94041	—
Not listed	New Haven	Connecticut	06511	—
Not listed	Washington D.C.	District of Columbia	20854	—
Not listed	Ocala	Florida	34471	—
Not listed	Tampa	Florida	33614	—
Not listed	Atlanta	Georgia	30308	—
Not listed	Augusta	Georgia	30901	—
Not listed	Newnan	Georgia	30265	—
Not listed	Peoria	Illinois	61603	—
Not listed	Shreveport	Louisiana	71101	—
Not listed	Shreveport	Louisiana	71103	—
Not listed	Bethesda	Maryland	20814	—
Not listed	Boston	Massachusetts	02135	—
Not listed	Detroit	Michigan	48236	—
Not listed	St Louis	Missouri	63136	—
Not listed	Broken Bow	Nebraska	68822	—
Not listed	Lebanon	New Hampshire	03756	—
Not listed	Flushing	New York	11355	—
Not listed	New York	New York	10016	—
Not listed	New York	New York	10029	—
Not listed	Orchard Park	New York	14127	—
Not listed	Raleigh	North Carolina	27609	—
Not listed	Columbus	Ohio	43210	—
Not listed	Portland	Oregon	97213	—
Not listed	Erie	Pennsylvania	16176	—
Not listed	Lancaster	Pennsylvania	17604	—
Not listed	Greenville	South Carolina	29605	—
Not listed	Sumter	South Carolina	29150	—
Not listed	Chattanooga	Tennessee	37404	—
Not listed	Knoxville	Tennessee	37923	—
Not listed	Austin	Texas	78758	—
Not listed	Houston	Texas	77074	—
Not listed	San Antonio	Texas	78212	—
Not listed	Alexandria	Virginia	22304	—
Not listed	Charlottesville	Virginia	22908	—
Not listed	Chesapeake	Virginia	23320	—
Not listed	Norfolk	Virginia	23507	—
Not listed	Bluefield	West Virginia	24701	—
Not listed	Appleton	Wisconsin	54911	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00255450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 11, 2008 · Synced Nov 15, 2026